Partner News | Published: Wednesday, April 16, 2025
iCardio.ai is a Los Angeles-based company advancing machine learning and deep learning algorithms for ultrasound, focusing on transthoracic echocardiography. With a proprietary database of over 200 million ultrasound images, iCardio.ai enhances diagnostic accuracy and efficiency through artificial intelligence (AI). Their flagship product, EchoMeasure™, recently received U.S. Food and Drug Administration (FDA) 510(k) clearance, providing clinicians with an automated, comprehensive imaging workflow and preliminary reporting tool. Additionally, CardioVision™, an AI-based aortic stenosis detection tool, earned FDA Breakthrough Device Designation, addressing unmet needs in cardiac diagnostics. iCardio.ai has also formed key partnerships, including a multi-year collaboration with GE Healthcare to integrate its technology into GE ultrasound platforms, as well as agreements with UltraLinQ and SARC MedIQ, broadening the accessibility and utility of echocardiography AI.
Partner News | Published: Wednesday, April 16, 2025
Hi-D Imaging is a medtech company revolutionizing structural heart disease treatment planning through artificial intelligence (AI)-powered software and digital twin-based hemodynamics risk assessment solutions. Founded in 2019, with technology development dating back to 2008, the company has developed cutting-edge software that enhances the clinical decision-making process. Their flagship product, 4TAVR, utilizes deep learning algorithms to provide highly accurate, personalized assessments of anatomical structures, enabling more precise pre-procedural planning. Additionally, Hi-D Imaging has pioneered a second product, Digital Twin-Based Hemodynamics Analysis, which mimics patient-specific cardiovascular conditions to predict blood flow abnormalities, risk assessment and the impact of medical devices before the actual implantation. This platform serves medical device companies and research institutions, optimizing innovation in cardiac care.
Partner News | Published: Wednesday, April 16, 2025
SoniVie and the HealthTech Arkansas Accelerator connected in 2021, before the program rebranded as HeartX. The SoniVie pilot study was a multi-center trial conducted across the U.S. St. Bernards Healthcare (SBHC) and Arkansas Heart Hospitals, two HeartX partner sites, played a valuable role in the study, with Arkansas Heart Hospital enrolling the first U.S. patient on May 5, 2023. By the end of 2023, SoniVie successfully completed enrollment of 25 patients across all trial sites, with the two HeartX-supported sites ranking among the top three enrolling sites.
Partner News | Published: Tuesday, April 8, 2025
Caristo Diagnostics, developer of a new artificial intelligence (AI)-powered heart disease detection solution allowing healthcare providers to identify hidden heart attack risks before symptoms appear.
Partner News | Published: Monday, March 31, 2025
US Heart & Vascular (USHV), a leading national provider of support services to cardiovascular physician practices, enabling independent cardiologists to increase patient access, improve outcomes, and reduce costs to the healthcare system.
News | Published: Saturday, March 29, 2025
Ginger K. Biesbrock, PA-C, DSc, MPH, FACC, has been awarded the 2025 Presidential Citation Award by the American College of Cardiology (ACC) in honor of her remarkable contributions to the cardiovascular profession. Biesbrock will be recognized for these achievements along with all 2025 Distinguished Award winners during Convocation at the ACC’s Annual Scientific Session (ACC.25) taking place March 29 – 31, 2025, in Chicago.
News | Published: Monday, March 17, 2025
The American College of Cardiology’s (ACC’s) five-year Strategic Plan includes a major initiative focused on transforming care delivery in new areas and recognizing the importance of delivering care within the communities where patients reside. As part of this initiative, the ACC and MedAxiom, an ACC Company focused on cardiovascular organizational improvement solutions, are partnering on a series of care transformation resources designed to provide a framework for health systems to effectively integrate novel paradigms of care into their delivery models.
News | Published: Monday, March 10, 2025
The cardiology world will come together for an unforgettable educational experience at ACC.25 at the McCormick Place Convention Center in Chicago, IL, March 29 – 31. ACC.25 provides opportunities to engage with peers from around the globe and learn the latest updates in the field with a focus on transforming cardiovascular care for all.
Partner News | Published: Thursday, March 6, 2025
Bunkerhill Health, a leader in AI-enabled early disease detection, and Cleerly, a pioneer in advanced cardiovascular imaging, have announced a strategic partnership to expand access to their technologies for coronary artery disease (CAD) detection and risk assessment.
News | Published: Monday, February 24, 2025
MedAxiom has been named the number one small business (<150 employees) for the third consecutive year as part of the Metro Jacksonville Top Workplaces 2024 Program. MedAxiom also received a specialty award for stellar communication.
By continuing to use our site, you agree to our Cookie Policy, Privacy Policy and Terms of Use.